Mesh : Humans Mohs Surgery Carcinoma, Basal Cell / surgery pathology radiotherapy Male Female Retrospective Studies Neoplasm Recurrence, Local / epidemiology Skin Neoplasms / surgery pathology radiotherapy Aged Middle Aged Ear Neoplasms / radiotherapy surgery pathology Aged, 80 and over Adult

来  源:   DOI:10.12788/cutis.1004

Abstract:
Basal cell carcinoma (BCC) of the ear may have aggressive histologic subtypes and a greater propensity for subclinical spread than BCC in other anatomic locations. In this retrospective analysis, we evaluated recurrence rates of BCC of the ear in 102 patients who underwent treatment with Mohs micrographic surgery (MMS) or radiation therapy (RT) at a single institution between January 2017 and December 2019. Data on patient demographics, tumor characteristics, treatment modality, and recurrence rates were collected from medical records. Recurrence rates were assessed over a mean follow-up time of 2.8 years. Although MMS is the gold standard for treatment of BCC of the ear, RT may be a suitable alternative for nonsurgical candidates.
摘要:
耳部基底细胞癌(BCC)可能具有侵袭性组织学亚型,并且在其他解剖位置比BCC具有更大的亚临床传播倾向。在这个回顾性分析中,我们评估了在2017年1月至2019年12月期间在一家机构接受Mohs显微手术(MMS)或放射治疗(RT)治疗的102例患者的耳部BCC复发率.患者人口统计数据,肿瘤特征,治疗方式,从医疗记录中收集复发率。在平均2.8年的随访时间内评估复发率。虽然MMS是治疗耳部BCC的金标准,RT可能是非手术候选人的合适替代方案。
公众号